Today’s AI Top Pick: ORCL

7/20/2026 · Undervalued Emerging screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Undervalued EmergingORCLBUY NOW8.8 / 107/20/2026

Oracle is the cleanest asymmetric setup in the pool right now: a mega-cap with world-class fundamentals (ROE 54.28%, profit margin 25.21%, operMargin 33.32%, salesYoY +17.35%) trading at fwdPe 11.59 with a PEG of 0.44 — deeply cheap for a hyperscaler. Sentiment is capitulatory (RSI 29.25, pos_in_21bar_range only 2.76% on the daily and 1.63% on the weekly, dd_from_21bar_high -31.47% daily / -44.07% weekly). That is exactly the profile the brief asks for: fundamentals confirmed, price NOT at the top of the range, drawdown acceptable. The forecast tape confirms a bounce with unusually large magnitudes across horizons: 1h fc_mid +24.03% / fc_long +25.41%, 4h fc_mid +25.92% / fc_long +41.93%, 1d fc_short +11.62% / fc_mid +41.17% / fc_long +47.60%, and even the beaten-up weekly turns positive on mid/long (+6.47% / +4.94%). Bullish_prob is 1.0 and near_term_bullish is 0.80 — the only mild yellow flag is the 1wk fc_short at -3.66%, consistent with a base still being carved. That is a coherent multi-timeframe agreement, not a single-bar outlier. News flow is a net positive despite the ugly print: the 52-week-low headline is priced in, while the IMSA Labs Cloud/AI Studio partnership (7/19) reinforces the AI-infrastructure narrative, and Motley Fool publicly disclosed buying after the 65% drawdown. There is no landmine here — no guidance cut, no litigation, no dilution — just multiple-compression on a name whose forward P/E is now below the S&P average. Contrast with FUTU (DOJ probe + class actions), CELH (UK ban chatter, price-target cuts), or HDB (weak margins, Nifty drag) where the news actively undercuts an otherwise passable setup. Why TODAY vs. waiting: the mid/long forecasts are 25–48% and the stock is already at bottom-decile position in every intraday range with an oversold RSI. Waiting for a further pullback risks missing the mean-reversion snapback the forecasts imply; buying here gives you a defined stop just below the recent low and 3–4x reward-to-risk into the mid-target.

Entry zone

$123.50 – $128.00 (scale in; current $125.85, low end near 21-bar floor)

Stop loss

$114.90 (below the 21-bar low, ~8.7% risk — invalidates the mean-reversion thesis)

First target

$142 (+13%, aligns with 1d fc_short +11.6% and reclaims mid-range)

Longer target

$178 – $185 (1d fc_mid +41.17% / fc_long +47.60%, back near pre-drawdown levels)

Risks

1wk fc_short is -3.66% — a further 5-10% flush before the bounce is a live possibility given -44% weekly drawdown
Debt/Equity 3.94 is elevated; a cloud-capex cycle miss in Q2 could pressure margins
Down 49.18% YoY and at 52-week lows — momentum traders will keep selling rallies until a higher-low prints
AI-capex narrative is fragile; any hyperscaler guidance cut sector-wide would drag ORCL
Recom 1.51 (Buy, not Strong Buy) suggests sell-side is not yet leaning in — analyst upgrades are a catalyst not yet in hand

Honorable mentions

ZTSfwdPe 10.39, ROE 67%, profit margin 27.8% at a -37% weekly drawdown with weekly forecasts of +51.6%/+94.9%/+123.9% — massive mean-reversion setup, though Neogen acquisition scrutiny + weight-loss-drug pet-obesity headline are ambiguous near-term overhangs.

FISCheapest large-cap in the list (fwdPe 6.12, PEG 0.64) with 1d fc_long +42% and 1wk fc_long +78.9%; Anthropic partnership is a real catalyst. Docked only because pos_in_21bar_range is already 86–95% intraday — a pullback entry would be preferable.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	ORCL	BUY NOW	8.8	Oversold hyperscaler at 2.76% of daily range with fc_mid +41% and clean AI catalyst — textbook mean-reversion.
2	ZTS	BUY NOW	8.1	67% ROE at fwdPe 10.4, weekly fc_long +123.9% off a -37% drawdown; only regulatory-scrutiny headline dings it slightly.
3	FIS	BUY PULLBACK	7.6	Cheapest name here (fwdPe 6.1) with 1wk fc_long +78.9%, but intraday pos 86-95% argues for waiting on a dip.
4	EXLS	BUY PULLBACK	7.3	All 4 timeframes green, analyst upgrade + 43.9% upside call, but pos 100/100/86 says don't chase.
5	TRMB	BUY PULLBACK	7.2	1d fc_mid +41.3%, positive tape into earnings, but pos 100% on 1h/1d means paying full price.
6	MORN	BUY PULLBACK	7.1	1wk fc_long +44.9%, PitchBook accolade, but pinned to top of 1h/4h range.
7	PDD	BUY PULLBACK	7.0	fwdPe 6.8, 1d fc_mid +31.6%, but pos 87-96% intraday and China-tech beta risk.
8	WAY	WAIT	6.8	1d fc_mid +49% strong but 1h fc all negative and KeyBanc 'misunderstood' thesis needs confirmation.
9	VNT	BUY PULLBACK	6.7	fwdPe 8.18, positive Seeking Alpha coverage, but weak near-term fcs and pos 80-88%.
10	PEGA	BUY PULLBACK	6.5	1d fc_long +52%, but pos 90/97/80 into Q2 earnings — event risk without margin of safety.
11	BILI	BUY PULLBACK	6.4	$300M buyback catalyst, 1d fc_mid +41.8%, but 1h/1wk fc_short negative and pos 97/100.
12	MNSO	BUY PULLBACK	6.3	1d fc_short +49.8%, PEG 0.17, but pos 100/100/99 and softer Zacks flow.
13	DCBO	WAIT	6.2	$70M SIB is a positive, 1wk fc_long +64%, but 1h/4h fc all negative — near-term air pocket.
14	ACM	BUY PULLBACK	6.1	Major infrastructure contract wins + ROE 27.7%; SWS 'slightly overvalued' caps upside.
15	AGI	BUY PULLBACK	5.9	PEG 0.23, RSI 32.7 oversold, 1d fc_mid +28.7%, but 1wk forecasts -13/-37/-49% — heavy overhead.
16	EXE	WAIT	5.8	Post-109% run, big earnings beat, but epsNextY -4.9 and weekly forecast negative.
17	LOPE	WAIT	5.7	pos 0/0/0 across intraday and PT cut from BMO — falling knife on GARP name.
18	ORLA	WAIT	5.6	PEG 0.13, 1d fc_short +32.9%, but 1wk forecasts -12/-30/-49% and CIBC PT cut.
19	EQX	WAIT	5.5	RSI 31 oversold with 1d fc_mid +28%, but 1wk fc_long -28% and RBC PT cut.
20	HDB	WAIT	5.4	Weak Q1 margin headline actively dragging Nifty today — thesis broken.
21	BZ	WAIT	5.3	Great margins (profit 40%), but pos 92-98% intraday and 1h/4h fc all negative.
22	GAU	WAIT	5.2	PEG 0.03, 4h fc_long +61.4%, but 1wk fc_long -38% signals structural weakness.
23	FINV	WAIT	5.1	fwdPe 3.33, all-time cheap, but pos 0/0 intraday and salesYoY only 0.84%.
24	DRD	WAIT	5.0	Peter Lynch GARP name, but 1wk fc_long -56.6% is a red flag.
25	KKR	WAIT	4.9	Bullish_prob only 0.60, 1h/4h forecasts flat-to-negative, PT cut from Oppenheimer.
26	NRDS	WAIT	4.8	PEG 0.27 attractive but no near-term catalyst until earnings and recom 2.0.
27	ITRG	AVOID	4.5	Zacks downgrade + 1wk fc_long -32.6%; near_term_bullish only 0.2.
28	CELH	AVOID	4.2	UK ban concerns + analyst PT cuts + fwdPe 14.67 — worst risk/reward here.
29	PGY	AVOID	3.9	1h/4h fc all negative, 1wk fc_long -49.5%, and 16.87% short float — falling knife.
30	FUTU	AVOID	3.5	DOJ probe + class actions is a live landmine that no forecast overrides.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord